Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  BIOYF

Biosyent Inc is a life science company engaged in marketing of pharmaceutical products & manufacturing & marketing of non-chemical bio & health-friendly insecticides. It acquires or license products & commercializes technology to health & public safety.
Price: $8.20 | Change: $-0.10 | %Change: -1.20%
Volume: 5,400 | Day High/Low: 8.36/8.17 | 52 Week High/Low: 12.82/4.72
View modes: 
0 stars

RE:Take a look at Chorus Aviation Inc....

CORRECTION: Ticker:   " T.CHR.B"  rate and reply
0 stars

Take a look at Chorus Aviation Inc....

T.CRH.B EPS (ttm) = $0.53 Hit new 52wk high today of $6.26 Dividend =  4 cents monthly per share!!! Cheers!  rate and reply
5 stars

Bloom Burton Conference May 4-5 2015

Æterna Zentaris   ESSA Pharmaceuticals   Patient Home Monitoring Agility Health   Formation Biologics   Pediapharm more
5 stars

T.GUD moves ahead of V.RX....

T.GUD : $8.22          V.RX :  $8.13 RX closing share price last 6 trading days:      April 17,2015       $8.76  down 39 cents          20,2015       $8.60  down 16 cents          21,2015       $ more
5 stars

Lower Highs and Lower Lows..........

This could be a great company! What needs to be done? Issue some stock,at least another 10M shares so you have a war chest to add to the pipeline while at the same time adding some much more
5 stars

Low Volume

There's no question that we could use some news to get our mojo back. Until that time, we are trading with little volume which leads to greater volatility which leads to our SP being nickeled more
5 stars

RE:To Iscfa for clarification

Light loud wrote: "....we can't deny some investors lost money from $12 to $8".....It's not a loss if you don't sell!!!!  rate and reply
3 stars

To Iscfa for clarification

Hi Iscfa, one thing to clarify, from a long-term investment perspective, both of us like Biosyent's business model (by adding 2 or 3 new products each year) and also its management. We all wish more
0 stars


Hi Iscfa, I won't say I agree or disagree with Cantor's opinion until we see Q1 2015 results on May 13, 2015.  rate and reply
5 stars


Joined April 16, 2015. Get off your lazy but and go back and read some older posts. It was exp[lained by several posters that the generic scare is a red herring. Cantor said: "We feel the market more
1 star


Hi Iscfa, Cantor's target is just Cantor's target. They don't have crystal ball either. Based on Biosyent press release on (May 22, 2013): "Q1 2013 Pharmaceutical Sales were up by 72% versus Q1 2012"; more
3 stars


Stop thinking like a myopic day trader. Cantor has a one year target of $13.25 .  rate and reply
3 stars

Looking at the one year chart.....

The last five months , it is clearly a case of LOWER HIGHS and LOWER LOWS and that will result in a lower share price over time. The recent drop to $6.80 was no fluke!!! Cheers and Happy Investing!  rate and reply
3 stars


Hi Iscfa, That's great you bought Biosyent stock at $0.30, you are still making money no matter it's up or down. But how about the people who bought at $11-12 and now stuck at $8? lscfa - (4/19/2015 more
5 stars


Lightcloud wrote: Hi Iscfa, did you buy Biosyent stock at $11?... I bought at $0.30 and haven't sold a share.  rate and reply
1 star

RE:RE:RE:From the CPH BB

Hi Iscfa, did you buy Biosyent stock at $11?  rate and reply
3 stars

To Uplist or to not?.......

RX share price has fallen from a high of $12.82 to $8.76  ,a drop of $4.06 Chairman, Mike Dalsin of V.PHM in talking with James West of Midas Letter: " If we're a venture stock , you know, we' more
2.5 stars

RE:RE:From the CPH BB

Don't hold your breath dumbass. RX is never falling to $4 to $5......Lightcloud wrote: If Cipher really wants to buy Biosyent, Biosyent V.Rx's $8.70 is not a good price yet. Cipher may consider more
3.5 stars

RE:From the CPH BB

If Cipher really wants to buy Biosyent, Biosyent V.Rx's $8.70 is not a good price yet. Cipher may consider when Biosyent drops to $4 - 5 range. retiredcf - (4/19/2015 7:45:34 AM): Biosyent V.Rx more
0 stars

From the CPH BB

One person's suggestion. GLTA Biosyent V.Rx is dropping maybe Cipher will buy it? Biosyent is getting down to a valuation where Cipher can buy up Biosyent for a good price. It has some more